Profusa, Inc. (PFSA)

NASDAQ: PFSA · Real-Time Price · USD
0.3064
-0.0241 (-7.29%)
At close: Sep 5, 2025, 4:00 PM
0.3040
-0.0024 (-0.78%)
After-hours: Sep 5, 2025, 7:55 PM EDT
-7.29%
Market Cap10.05M
Revenue (ttm)75,000
Net Income (ttm)-9.81M
Shares Out 32.79M
EPS (ttm)-1.75
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume654,593
Open0.3206
Previous Close0.3305
Day's Range0.3023 - 0.3300
52-Week Range0.3023 - 5.5000
Beta-0.13
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2025

About PFSA

Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. The company offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. It also researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California. [Read more]

Sector Healthcare
Founded 2009
Employees 15
Stock Exchange NASDAQ
Ticker Symbol PFSA
Full Company Profile

Financial Performance

In 2024, Profusa's revenue was $100,000, an increase of 122.22% compared to the previous year's $45,000. Losses were -$9.23 million, -10.22% less than in 2023.

Financial Statements

News

Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base

Internationally recognized vascular surgeon, Dr. Koen Deloose provides patient access to latest innovative treatments and personalized care

3 days ago - GlobeNewsWire

Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria

Led by Prof. Dr. Marianne Brodmann, PI of clinical studies for the Lumee™ Oxygen CE Mark, collaboration includes practice adoption and platform integration in cases and clinical study programs

11 days ago - GlobeNewsWire

Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O'Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO

Board addition served in the Trump Administration, overseeing 1,300 facilities serving more than 9 million veterans; New CFO has led finance and operations at companies including Northrop Grumman, Sta...

19 days ago - GlobeNewsWire

Profusa, Inc. Provides Strategy Overview and Business Update for Investors

BERKELEY, Calif, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology pla...

4 weeks ago - GlobeNewsWire

Profusa Secures Lumee™ Oxygen Platform Distributor in Spain

BERKELEY, Calif, July 31, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology pla...

5 weeks ago - GlobeNewsWire

Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy

BERKELEY, Calif, July 21, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology pla...

6 weeks ago - GlobeNewsWire

Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq

Profusa's Common Stock is Expected to Begin Trading on Nasdaq on Monday, July 14, 2025 Under the Ticker "PFSA" BERKELEY, Calif, July 11, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Compa...

2 months ago - GlobeNewsWire